BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[Biostar Pharmaceuticals, Inc. Begins Assembly of New Production Line Increases overall capacity by $30 million annually and paves way for entrance into the Military Pharmaceutical Market XIANYANG, China, May 25, 2010 (Xinhua-PRNewswire-FirstCall) BSPM News Biostar completed Chinese Military Drug Administration clinical trials for Zushima Analgesic Aerosol Spray (“Zushima”) in April through the Chinese No. 4 Military Medical University. Zushima is]

By | 2016-03-03T14:22:20+00:00 May 25th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: Biostar Pharmaceuticals, Inc. Begins Assembly of New Production

[Biostar Pharmaceuticals, Inc. Begins Assembly of New Production Line Increases overall capacity by $30 million annually and paves way for entrance into the Military Pharmaceutical Market XIANYANG, China, May 25, 2010 (Xinhua-PRNewswire-FirstCall) BSPM News Biostar completed Chinese Military Drug Administration clinical trials for Zushima Analgesic Aerosol Spray (“Zushima”) in April through the Chinese No. 4 Military Medical University. Zushima is]

By | 2016-03-03T14:23:29+00:00 May 25th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

CISG [CNINSURE] 6-K: (Original Filing)

[IR-073 CNinsure Reports First Quarter 2010 Unaudited Financial Results – Earnings Exceed Prior Guidance – – Basic Net Income Per ADS up 47.9% to RMB1.476 (US$0.216) – – 35% Year-over-Year Growth for Earnings Expected for Second Quarter 2010 – CISG 1 GUANGZHOU, China, May 24, 2010/ PRNewswire-Asia-FirstCall/— CNinsure Inc., (Nasdaq: Financial Highlights for First Quarter 2010: • Total net revenues:] [FORM 6-K CNINSURE INC. 22/F, Yinhai Building þ o Form 20-F o Rule 101(b)(1): o Rule 101(b)(7): CNinsure Inc. Yinan Hu Chief Executive Officer — Press release 6-K 1 c01711e6vk.htm FORM 6-K]

CISG [CNINSURE] 6-K: IR-073 CNinsure Reports First Quarter 2010 Unaudited Financial

[IR-073 CNinsure Reports First Quarter 2010 Unaudited Financial Results – Earnings Exceed Prior Guidance – – Basic Net Income Per ADS up 47.9% to RMB1.476 (US$0.216) – – 35% Year-over-Year Growth for Earnings Expected for Second Quarter 2010 – CISG 1 GUANGZHOU, China, May 24, 2010/ PRNewswire-Asia-FirstCall/— CNinsure Inc., (Nasdaq: Financial Highlights for First Quarter 2010: • Total net revenues:] [FORM 6-K CNINSURE INC. 22/F, Yinhai Building þ o Form 20-F o Rule 101(b)(1): o Rule 101(b)(7): CNinsure Inc. Yinan Hu Chief Executive Officer — Press release 6-K 1 c01711e6vk.htm FORM 6-K]

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[Biostar Pharmaceuticals, Beginssembly of New Production Linereases overallpacity by $30 million annually and paves way for entrance into the Military Pharmaceutical Market XIANYANG, China, May 25, 2010 (Xinhua-PRNewswire-FirstCall) BSPM News Biostarmpleted Chinese Military Drugministration clinical trials for Zushima Analgesicrosolray (Zushima) in April through the Chinese No. 4 Military Medical University. Zushima is a traditional Chinese]

By | 2016-02-07T17:23:04+00:00 May 25th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: Biostar Pharmaceuticals, Beginssembly of New Production Linereases overallpacity

[Biostar Pharmaceuticals, Beginssembly of New Production Linereases overallpacity by $30 million annually and paves way for entrance into the Military Pharmaceutical Market XIANYANG, China, May 25, 2010 (Xinhua-PRNewswire-FirstCall) BSPM News Biostarmpleted Chinese Military Drugministration clinical trials for Zushima Analgesicrosolray (Zushima) in April through the Chinese No. 4 Military Medical University. Zushima is a traditional Chinese]

By | 2016-02-07T17:23:59+00:00 May 25th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar